AOA Code |
Course Description |
Primary Speaker |
Additional Speaker |
Additional Speaker |
Additional Speaker |
Credits |
Course Type |
AOA Expiration |
Virtual Option |
AOA252-TD |
TD-A Brief Overview of the More Common Indications for Lab Studies |
James Fanelli, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
3/3/2025 |
No |
AOA382-TD |
TD-A Modern Approach to Dry Eye |
Jessilin Quint, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
4/17/2026 |
Yes |
AOA253-TD |
TD-Advanced Procedures with RadioFrequency |
Selina McGee, O.D. |
Nathan Lighthizer, O.D. |
N/A |
N/A |
2 |
OD |
3/7/2025 |
Yes |
AOA254-TD |
TD-Age Related Macular Degeneration - 2022 Update |
Elena Biffi, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
3/30/2025 |
Yes |
AOA359-TD |
TD-AMD Updates: Staying Current with its Landscape |
Jay Haynie, O.D. |
Mohammad Rafieetary, O.D. |
N/A |
N/A |
2 |
OD |
12/15/2025 |
No |
AOA254-TD |
TD-Anterior Segment Grand Rounds |
Blair Lonsberry, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
12/31/2025 |
No |
AOA256-TD |
TD-Applications of Angiography (FA, ICG, OCTA) |
Jessica Haynes, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
12/31/2025 |
Yes |
AOA258-TD |
TD-Battle of the Omegas - Comparing Nutritional Strategies in Dry Eye Disease |
Mark Roark, O.D. |
N/A |
N/A |
N/A |
1 |
OD/PARA |
12/31/2025 |
Yes |
AOA260-TD |
TD-Beauty Confidential |
Selina McGee, O.D. |
Leslie O'Dell, O.D. |
Tracy Doll, O.D. |
N/A |
2 |
OD |
3/3/2025 |
Yes |
AOA345-TD |
TD-Benefits of Managing the Eyelid Margin in Meibomian Gland Dysfunction |
Srihari Narayanan, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
12/5/2025 |
Yes |
AOA261-TD |
TD-Beyond the Posterior Pole |
Carolyn Majcher, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
3/9/2025 |
Yes |
AOA364-TD |
TD-Caution Steep Hill Ahead: Managing Keratoconus in Clinical Practice: Are you Ready to Conquer Keratoconus? |
Melissa Barnett, O.D. |
N/A |
N/A |
N/A |
1 |
OD/PARA |
12/6/2025 |
Yes |
AOA265-TD |
TD-Contemporary Diabetic Retinopathy Care |
Carolyn Majcher, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
3/2/2025 |
Yes |
AOA387-TD |
TD-Contemporary Keratoconus |
Steven Sorkin, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
4/17/2025 |
Yes |
AOA385-TD |
TD-Corneal Collagen Crosslinking (CXL): MD and OD Perspective |
Susan Gromacki, O.D. |
Jonathan Etter, O.D. |
N/A |
N/A |
2 |
OD |
4/25/2026 |
Yes |
AOA354-TD |
TD-Demodex Diaries |
Cecelia Koetting, O.D. |
N/A |
N/A |
N/A |
1 |
OD/PARA |
12/19/2025 |
Yes |
AOA274-TD |
TD-Eyelid Ptosis: Make the Right Diagnosis |
Susan Gromacki, O.D. |
Shane Foster, O.D. |
N/A |
N/A |
1 |
OD |
3/7/2025 |
Yes |
AOA343-TD |
TD-From Retinal Findings to Systemic Diagnosis |
Carolyn Majcher, O.D. |
Daniel Epshtein, O.D. |
N/A |
N/A |
1 |
OD |
12/7/2025 |
Yes |
AOA377-TD |
TD-How to Heal When You Can’t Feel – Neurotrophic Keratitis Update |
Jacob Lang, O.D. |
Clark Chang, O.D. |
N/A |
N/A |
1 |
OD |
3/7/2026 |
Yes |
AOA277-TD |
TD-Imaging the Anterior Segment |
Steven Sorkin, O.D. |
N/A |
N/A |
N/A |
1 |
OD/PARA |
3/2/2025 |
Yes |
AOA280-TD |
TD-Innovations in Ocular Surface Disease to Maximize Patient Outcomes |
Walter Whitley, O.D. |
Derek Cunningham, O.D. |
Justin Schweitzer, O.D. |
Tracy Doll, O.D. |
2 |
OD |
3/3/2025 |
Yes |
AOA271-TD |
TD-Intravitreal Injections - What Optometry Should Know |
Jay Haynie, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
12/31/2025 |
Yes |
AOA232-TD |
TD-Lids and Lashes on the Cutting Edge |
Spencer Johnson, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
3/3/2025 |
Yes |
AOA388-TD |
TD-Lumps and Bumps: A Practical Guide to Evaluation and Management |
Nate Lighthizer, O.D. |
Leonid Skorin, O.D., O.D. |
N/A |
N/A |
2 |
OD |
4/5/2026 |
Yes |
AOA209-TD |
TD-Minor Surgical Procedures |
Jason Duncan, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
3/3/2025 |
Yes |
AOA344-TD |
TD-New Developments in Anti-VEGF Therapy |
Daniel Epshtein, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
12/2/2025 |
Yes |
AOA238-TD |
TD-OCT Angiography Grand Rounds |
Carolyn Majcher, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
12/31/2025 |
Yes |
AOA380-TD |
TD-On Call with Melton and Vollmer |
Norman Melton, O.D. |
Patrick Vollmer, O.D. |
N/A |
N/A |
2 |
OD |
3/14/2026 |
Yes |
AOA294-TD |
TD-Optometry & Genetics: The Future of Precision Medicine |
Rachelle Lin, O.D. |
N/A |
N/A |
N/A |
1 |
OD/PARA |
3/8/2025 |
Yes |
AOA218-TD |
TD-Panel Discussion: Is There a Treatment for Me? Genetic Testing, Clinical Trials, Gene Therapy, & Future Treatments Q&A |
Rachelle Lin, O.D. |
Ben Shaberman, O.D. |
Jill Dolgin, PharmD |
N/A |
2 |
OD/PARA |
3/3/2025 |
Yes |
AOA295-TD |
TD-Peeling Back the Layers: A Case Based Trip Around the Cornea |
Jacob Lang, O.D. |
Scott Hauswirth, O.D. |
N/A |
N/A |
1 |
OD |
2/27/2025 |
Yes |
AOA289-TD |
TD-Retina OCT Workshop: How to Scan How to Interpret |
Mohammad Rafieetary, O.D. |
Roya Attar, O.D. |
Jessica Haynes, O.D. |
N/A |
2 |
OD/PARA |
12/31/2025 |
No |
AOA298-TD |
TD-Screening for Carcinoma of the Eyelids |
Richard Castillo, O.D., D.O. |
N/A |
N/A |
N/A |
1 |
OD |
3/3/2025 |
Yes |
AOA299-TD |
TD-Seeing White Dots |
Jessica Schiffbauer, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
3/1/2025 |
Yes |
AOA300-TD |
TD-Sensitivity Training; A Chronicle of Neurotrophic Keratitis (NK) Management |
Jacob Lang, O.D. |
Clark Chang, O.D. |
N/A |
N/A |
1 |
OD |
3/4/2025 |
Yes |
AOA293-TD |
TD-Solving the Scleritis Dilemma |
Erich Hinel, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
12/31/2025 |
Yes |
AOA305-TD |
TD-The Complete Course on Corneal Dystrophies and Degenerations |
Susan Gromacki, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
4/7/2025 |
Yes |
AOA308-TD |
TD-The Ocular Adnexa. Optometry's Next Frontier |
Selina McGee, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
4/13/2025 |
Yes |
AOA297-TD |
TD-Treatment Strategies for Refractory Ocular Surface Disease |
Ahmad Fahmy, O.D. |
N/A |
N/A |
N/A |
1 |
OD |
12/31/2025 |
Yes |
AOA298-TD |
TD-Unraveling Intraocular Inflammation |
Erich Hinel, O.D. |
N/A |
N/A |
N/A |
2 |
OD |
12/31/2025 |
Yes |
AOA229-TD |
TD-Using IPL to address ocular surface and adnexal conditions |
Renee Reeder, O.D. |
N/A |
N/A |
N/A |
1 |
OD/PARA |
3/3/2025 |
Yes |
AOA301-TD |
TD-Worst Case Scenarios- A Co-Management Review of Ocular Trauma Emergencies from Pediatrics to Adults |
Angela Howell, O.D. |
Jade Coats, O.D. |
N/A |
N/A |
2 |
OD/PARA |
12/31/2025 |
Yes |